Cerebral vein thrombosis and lupus anticoagulant antibodies

Clinical and Applied Thrombosis/Hemostasis

Volumn 7, Issue 3, 2001, Pages 238-

  Marietta, Marco ^a   Bertesi, Marcello ^a   Simoni, Luisa ^a   Castelli, Ilaria ^a   Cappi, Cinzia ^a   Torelli, Giuseppe ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; ENOXAPARIN; HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LETTER; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASES; ENOXAPARIN; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; PULMONARY EMBOLISM; SAGITTAL SINUS THROMBOSIS; THROMBOPHLEBITIS; WARFARIN;

EID: 0034977608     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960100700311     Document Type: Letter

References (9)

1. Risk factors for venous thromboembolic disease
2. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome
3. The management of thrombosis in the antiphospholipid-antibody syndrome
4. On behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on the investigation and management of the antiphospholipid syndrome
5. Long-term treatment for venous thromboembolism
6. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis
7. Antiphospholipid antibodies and venous thromboembolism
8. Antithrombotic therapy for venous thromboembolic disease
9. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism